1. Home
  2. TEVA vs NTNX Comparison

TEVA vs NTNX Comparison

Compare TEVA & NTNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • NTNX
  • Stock Information
  • Founded
  • TEVA 1901
  • NTNX 2009
  • Country
  • TEVA Israel
  • NTNX United States
  • Employees
  • TEVA N/A
  • NTNX N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • NTNX Computer Software: Prepackaged Software
  • Sector
  • TEVA Health Care
  • NTNX Technology
  • Exchange
  • TEVA Nasdaq
  • NTNX Nasdaq
  • Market Cap
  • TEVA 21.2B
  • NTNX 20.5B
  • IPO Year
  • TEVA N/A
  • NTNX 2016
  • Fundamental
  • Price
  • TEVA $25.46
  • NTNX $65.80
  • Analyst Decision
  • TEVA Strong Buy
  • NTNX Buy
  • Analyst Count
  • TEVA 7
  • NTNX 15
  • Target Price
  • TEVA $25.86
  • NTNX $88.07
  • AVG Volume (30 Days)
  • TEVA 13.5M
  • NTNX 1.8M
  • Earning Date
  • TEVA 11-05-2025
  • NTNX 11-25-2025
  • Dividend Yield
  • TEVA N/A
  • NTNX N/A
  • EPS Growth
  • TEVA N/A
  • NTNX N/A
  • EPS
  • TEVA 0.62
  • NTNX 0.65
  • Revenue
  • TEVA $16,776,000,000.00
  • NTNX $2,537,927,000.00
  • Revenue This Year
  • TEVA $4.11
  • NTNX $17.50
  • Revenue Next Year
  • TEVA $0.40
  • NTNX $14.32
  • P/E Ratio
  • TEVA $41.18
  • NTNX $101.20
  • Revenue Growth
  • TEVA 0.02
  • NTNX 18.11
  • 52 Week Low
  • TEVA $12.47
  • NTNX $54.66
  • 52 Week High
  • TEVA $26.38
  • NTNX $83.36
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 76.90
  • NTNX 37.89
  • Support Level
  • TEVA $23.61
  • NTNX $67.75
  • Resistance Level
  • TEVA $26.38
  • NTNX $72.54
  • Average True Range (ATR)
  • TEVA 0.84
  • NTNX 1.99
  • MACD
  • TEVA 0.45
  • NTNX -0.24
  • Stochastic Oscillator
  • TEVA 86.22
  • NTNX 21.21

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About NTNX Nutanix Inc.

Nutanix Inc is engaged in cloud software, offering organizations a single platform for running applications and managing data, anywhere. Its Nutanix Cloud Platform is designed to enable organizations to build a hybrid multicloud infrastructure, providing a consistent cloud operating model with a single platform for running applications and managing data in core data centers, at the edge, and in public clouds, all while supporting a variety of hypervisors and container platforms. The company is into a single operating and reportable segment that is subscription-based business model. Key revenue is generated from United States.

Share on Social Networks: